Dr Reddy’s Laboratories Ltd has announced the launch of Aspirin and extended-release Dipyridamole capsules, a therapeutic equivalent generic version of Aggrenox (aspirin and extended-release Dipyridamole) capsules in the US market.
The Aggrenox brand and generic had US sales of approximately $182 million for the most recent 12 months ended in October, according to IMS Health.
Dr Reddy’s Aspirin and extended-release Dipyridamole capsules is available in 25 mg/200 mg strength with 60 count bottle size. Aggrenox is a trademark of Boehringer Ingelheim.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.